| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 10.042 | 20.990 | 23.895 | 7.910 | 850 | 3.540 | 4.501 | 433 | 1.138 |
| Total Income - EUR | - | 10.042 | 61.626 | 23.902 | 7.970 | 850 | 3.540 | 4.782 | 736 | 1.138 |
| Total Expenses - EUR | - | 15.767 | 56.844 | 23.741 | 7.211 | 432 | 480 | 639 | 730 | 773 |
| Gross Profit/Loss - EUR | - | -5.726 | 4.782 | 161 | 759 | 418 | 3.060 | 4.143 | 6 | 365 |
| Net Profit/Loss - EUR | - | -5.911 | 2.933 | -557 | 519 | 391 | 2.950 | 4.000 | 6 | 311 |
| Employees | - | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Onco Spero Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 41.332 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 639 | 2.889 | 4.178 | 2.050 | 2.824 | 5.373 | 4.352 | 4.262 | 4.549 |
| Inventories | - | 0 | 16 | 16 | 16 | 16 | 15 | 0 | 0 | 0 |
| Receivables | - | 579 | 613 | 1.703 | 400 | 740 | 1.892 | 1.037 | 319 | 867 |
| Cash | - | 60 | 2.260 | 2.459 | 1.634 | 2.068 | 3.466 | 3.315 | 3.943 | 3.682 |
| Shareholders Funds | - | -6.916 | -3.866 | -4.352 | -3.748 | -3.287 | -264 | 3.735 | 3.729 | 4.019 |
| Social Capital | - | 223 | 219 | 215 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debts | - | 48.888 | 6.756 | 8.530 | 5.798 | 6.111 | 5.637 | 618 | 533 | 530 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Onco Spero Srl